Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03118687 · ClinicalTrials.gov registry record
Human Immunome Program
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 2
- Enrollment target
NCT03118687 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 2 participants.
The verdict
NCT03118687 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The Human Immunome Program is a large-scale, open-source effort seeking to fill a major gap in our knowledge of the immune system. The power of the immune system to fight disease lies in its ability recognize and adapt to an astonishing range of threats from viruses, parasites and bacteria to cancer cells. Underlying this ability is a vast but specific set of genes and molecular structures known as the human immunome, or the "parts list" of the immune system. This study aims to decipher the genetic sequences that make up this part list and link it to information about a person's microbiome composition and characteristics such as health history, race, and demographics over time. This information, made freely available to the public for use in research in de-identified form, will allow investigators to answer a wide variety of different questions about immune system function. This could transform how we diagnose, prevent and treat disease though the identification of new biomarkers while enabling highly targeted, computationally designed vaccines and therapies that reduce time and risk of product development.
Interventions
- OTHER Biospecimen and survey collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2020-06-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03118687
The ClinicalTrials.gov registry entry for NCT03118687 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biospecimen and survey collection is the first listed.
NCT03118687 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03118687 about?
NCT03118687 is a clinical study titled "Human Immunome Program". The Human Immunome Program is a large-scale, open-source effort seeking to fill a major gap in our knowledge of the immune system. The power of the immune system to fight disease lies in its ability recognize and adapt to an astonishing range of threats from viruses, parasites and bacteria to cancer...
What is the current status of trial NCT03118687?
This trial is currently completed. The enrollment target is 2 participants. The study started on 2017-07-01. Estimated completion is 2020-06-18.
What interventions are being tested in trial NCT03118687?
The interventions under investigation include: Biospecimen and survey collection (OTHER).
Who is sponsoring clinical trial NCT03118687?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.